IONS
Ionis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang -6.2% ·
aliran saham +1.5% ·
posisi baru bersih -6.7%
— formula
Akumulasi terkonsentrasi — peningkatan saham di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +2 | 148.59M | $11.08B | +6 | −3 |
| Q1 2026 | 139 | -2 | 142.62M | $9.86B | +6 | −9 |
| Q4 2025 | 142 | 0 | 143.10M | $10.36B | +1 | — |
| Q3 2025 | 25 | +4 | 95.56M | $6.25B | +5 | −2 |
| Q2 2025 | 19 | +1 | 95.25M | $3.76B | +1 | — |
| Q1 2025 | 15 | -1 | 43.90M | $1.32B | +1 | −2 |
| Q4 2024 | 16 | -1 | 43.25M | $1.51B | — | −1 |
| Q3 2024 | 16 | -1 | 34.86M | $1.40B | — | −1 |
| Q2 2024 | 17 | — | 24.68M | $1.18B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 12.36M | +7.8% | $372.96M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 8.42M | -3.0% | $253.92M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (pasif) | 4.85M | -10.7% | $146.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | State Street Global Advisors ✦ (pasif) | 4.85M | -10.7% | $146.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (pasif) | 4.85M | -10.7% | $146.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 3.48M | +60.7% | $104.99M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 3.48M | +60.7% | $104.99M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 3.27M | -14.7% | $98.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 3.27M | -14.7% | $98.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Tweedy, Browne ✦ | 2.98M | -8.2% | $90.01M | 8.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasif) | 2.84M | +5.8% | $85.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | Geode Capital Management ✦ (pasif) | 2.84M | +5.8% | $85.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 1.69M | +83.0% | $50.86M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 1.08M | +291.1% | $32.45M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 23 | ARK Investment Management ✦ | 1.00M | -2.4% | $30.19M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 24 | Norges Bank ✦ (pasif) | 858.23K | -50.0% | $25.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Millennium Management ✦ | 635.37K | -17.9% | $19.17M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Point72 Asset Management ✦ | 287.20K | Baru | $8.66M | 0.0% | New | 1 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 153.51K | -25.3% | $4.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | Marshall Wace ✦ | 9.10K | -98.9% | $274,608 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $8.66M | 0.0% |
Telah keluar
| D. E. Shaw & Co. | $808,380 | adalah 0.0% |
| Gotham Asset Management | $218,850 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 490 pemegang, 170.17M saham, $11.94B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.